Metabolism and nutrition disorders

Disease1 paper1 finding

  • In silico1

Associations

1

SGLT-2 inhibitor + metformin

upin humans1Moderate certainty

1 study

  1. SGLT-2 inhibitor + metformin is associated with metabolism and nutrition disorders in humans (ROR = 9.00).

    Humanspharmacovigilance disproportionality analysis

    Adverse event reporting signals for SGLT-2 inhibitor-metformin combination therapy: a disproportionality analysis of the FAERS database · Frontiers in endocrinology · 4 Sep 2026

SGLT-2 inhibitor + metformin →

Trial sponsors

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01

Related